Verona Pharma Plc - ADR
VRNA
Market Cap$9B
Close$
$35.15
66.9% downside
Current Fair Value
66.9% downsideOvervalued by 66.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.00 Billion |
|---|---|
| Enterprise Value | $8.81 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.16 |
| Beta | 0.12 |
| Outstanding Shares | 85,644,375 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -111.72 |
|---|---|
| PEG | 95.63 |
| Price to Sales | 53.09 |
| Price to Book Ratio | 35.39 |
| Enterprise Value to Revenue | 39.73 |
| Enterprise Value to EBIT | -79.47 |
| Enterprise Value to Net Income | -109 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.88 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Verona Pharma Plc
CEO: David Zaccardelli